Atlas Trials

Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer

Clinical trial NCT00063388 · COMPLETED

Trial details

NCT number
NCT00063388
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small-Cell Lung Cancer
Start date
2003-05-01
Primary completion
2005-06-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.